Reuters logo
BRIEF-Baxter International ‍announces commercial launch of new indication for oXiris set​
2017年9月26日 / 下午2点21分 / 25 天前

BRIEF-Baxter International ‍announces commercial launch of new indication for oXiris set​

Sept 26 (Reuters) - Baxter International Inc :

* Baxter launches first 3-in-1 set for use in continuous renal replacement therapy and sepsis management protocols

* Baxter International Inc - ‍announced commercial launch of a new indication for company’s oXiris set​

* Baxter International Inc - ‍Baxter currently plans to file for expanded indication for oXiris set in additional countries in 2018 and beyond​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below